146
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Association of Red Cell Index and Hospital Mortality in Chronic Obstructive Pulmonary Disease Patients Admitted to the Intensive Care Unit: A Retrospective Cohort Study

ORCID Icon, ORCID Icon, ORCID Icon &
Pages 2267-2276 | Received 24 Jul 2023, Accepted 03 Oct 2023, Published online: 16 Oct 2023

References

  • Christenson SA, Smith BM, Bafadhel M, Putcha N. Chronic obstructive pulmonary disease. Lancet. 2022;399(10342):2227–2242. doi:10.1016/S0140-6736(22)00470-6
  • Barnes PJ. Inflammatory mechanisms in patients with chronic obstructive pulmonary disease. J Allergy Clin Immunol. 2016;138(1):16–27. doi:10.1016/j.jaci.2016.05.011
  • Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the global burden of disease study 2010. Lancet. 2012;380(9859):2095–2128. doi:10.1016/S0140-6736(12)61728-0
  • MacLeod M, Papi A, Contoli M, et al. Chronic obstructive pulmonary disease exacerbation fundamentals: diagnosis, treatment, prevention and disease impact. Respirology. 2021;26(6):532–551. doi:10.1111/resp.14041
  • Funk GC, Bauer P, Burghuber OC, et al. Prevalence and prognosis of COPD in critically ill patients between 1998 and 2008. Eur Respir J. 2013;41(4):792–799. doi:10.1183/09031936.00226411
  • Guang Y, Jie Z, Feng D, et al. Surrogate scale for evaluating respiratory function based on complete blood count parameters. J Clin Lab Anal. 2018;32(5):e22385. doi:10.1002/jcla.22385
  • Huang Y, Wang J, Shen J, et al. Relationship of red cell index with the severity of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2021;16:825–834. doi:10.2147/COPD.S292666
  • Babaoglu E, Ulasli SS. Clinical importance of red cell distribution width and red cell index in pulmonary embolism. Eur Rev Med Pharmacol Sci. 2023;27(9):4108–4115. doi:10.26355/eurrev_202305_32319
  • Qian M, Zhou X, Gao B, et al. Red cell index: a novel biomarker for 3-month mortality in acute ischemic stroke patients treated with intravenous thrombolysis. Brain Behav. 2021;11(6):e02170. doi:10.1002/brb3.2170
  • Yuan FZ, Shui W, Xing Y-L, et al. Association of red cell index and adverse hospitalization outcomes in chronic obstructive pulmonary disease patients with acute exacerbation: a retrospective cohort study. Int J Chron Obstruct Pulmon Dis. 2022;17:2263–2275. doi:10.2147/COPD.S373114
  • Johnson AEW, Bulgarelli L, Shen L, et al. MIMIC-IV, a freely accessible electronic health record dataset. Sci Data. 2023;10(1):1. doi:10.1038/s41597-022-01899-x
  • Guo X, Lin H, Guo D, et al. Azithromycin use prior to ICU admission is associated with a lower short-term mortality for critically ill acute exacerbations of chronic obstructive pulmonary disease patients: a retrospective cohort study. Chron Respir Dis. 2022;19:14799731221140797. doi:10.1177/14799731221140797
  • Qiu Y, Wang Y, Shen N, et al. Association between red blood cell distribution width-albumin ratio and hospital mortality in chronic obstructive pulmonary disease patients admitted to the intensive care unit: a retrospective study. Int J Chron Obstruct Pulmon Dis. 2022;17:1797–1809. doi:10.2147/COPD.S371765
  • Ling M, Huiyin L, Shanglin C, et al. Relationship between human serum albumin and in-hospital mortality in critical care patients with chronic obstructive pulmonary disease. Front Med. 2023;10:1109910. doi:10.3389/fmed.2023.1109910
  • Yang Q, Zheng J, Chen W, et al. Association between preadmission metformin use and outcomes in intensive care unit patients with sepsis and type 2 diabetes: a cohort study. Front Med. 2021;8:640785. doi:10.3389/fmed.2021.640785
  • Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–383. doi:10.1016/0021-9681(87)90171-8
  • Austin PC, White IR, Lee DS, et al. Missing data in clinical research: a tutorial on multiple imputation. Can J Cardiol. 2021;37(9):1322–1331. doi:10.1016/j.cjca.2020.11.010
  • Tariq S, Ismail D, Thapa M, et al. Chronic obstructive pulmonary disease and its effect on red blood cell indices. Cureus. 2023;15(3):e36100. doi:10.7759/cureus.36100
  • Xu L, Chen Y, Xie Z, et al. High hemoglobin is associated with increased in-hospital death in patients with chronic obstructive pulmonary disease and chronic kidney disease: a retrospective multicenter population-based study. BMC Pulm Med. 2019;19(1):174. doi:10.1186/s12890-019-0933-4
  • Santos MC, Oliveira AL, Viegas-Crespo AM, et al. Systemic markers of the redox balance in chronic obstructive pulmonary disease. Biomarkers. 2004;9(6):461–469. doi:10.1080/13547500400024768
  • Hoepers AT, Menezes MM, Fröde TS. Systematic review of anaemia and inflammatory markers in chronic obstructive pulmonary disease. Clin Exp Pharmacol Physiol. 2015;42(3):231–239. doi:10.1111/1440-1681.12357
  • Similowski T, Agusti A, MacNee W, et al. The potential impact of anaemia of chronic disease in COPD. Eur Respir J. 2006;27(2):390–396. doi:10.1183/09031936.06.00143704
  • Ergan B, Ergün R. Impact of anemia on short-term survival in severe COPD exacerbations: a cohort study. Int J Chron Obstruct Pulmon Dis. 2016;11:1775–1783. doi:10.2147/COPD.S111758
  • Toft-Petersen AP, Torp-Pedersen C, Weinreich UM, et al. Association between hemoglobin and prognosis in patients admitted to hospital for COPD. Int J Chron Obstruct Pulmon Dis. 2016;11:2813–2820. doi:10.2147/COPD.S116269
  • Criner GJ. Effects of long-term oxygen therapy on mortality and morbidity. Respir Care. 2000;45(1):105–118.
  • Vlahakos V, Marathias K, Lionaki S, et al. The paradigm shift from polycythemia to anemia in COPD: the critical role of the renin-angiotensin system inhibitors. Expert Rev Respir Med. 2022;16(4):391–398. doi:10.1080/17476348.2022.2045958
  • Drewry AM, Samra N, Skrupky LP, et al. Persistent lymphopenia after diagnosis of sepsis predicts mortality. Shock. 2014;42(5):383–391. doi:10.1097/SHK.0000000000000234
  • Şahin F, Koşar AF, Aslan AF, et al. Serum biomarkers in patients with stable and acute exacerbation of chronic obstructive pulmonary disease: a comparative study. J Med Biochem. 2019;38(4):503–511. doi:10.2478/jomb-2018-0050
  • Günay E, Sarınç Ulaşlı S, Akar O, et al. Neutrophil-to-lymphocyte ratio in chronic obstructive pulmonary disease: a retrospective study. Inflammation. 2014;37(2):374–380. doi:10.1007/s10753-013-9749-1
  • Sørensen AK, Holmgaard DB, Mygind LH, et al. Neutrophil-to-lymphocyte ratio, calprotectin and YKL-40 in patients with chronic obstructive pulmonary disease: correlations and 5-year mortality - a cohort study. J Inflamm. 2015;12(1):20. doi:10.1186/s12950-015-0064-5
  • Cao Y, Xing Z, Long H, et al. Predictors of mortality in COPD exacerbation cases presenting to the respiratory intensive care unit. Respir Res. 2021;22(1):77. doi:10.1186/s12931-021-01657-4
  • Acanfora D, Scicchitano P, Carone M, et al. Relative lymphocyte count as an indicator of 3-year mortality in elderly people with severe COPD. BMC Pulm Med. 2018;18(1):116. doi:10.1186/s12890-018-0685-6
  • Rahimi-Rad MH, Soltani S, Rabieepour M, et al. Thrombocytopenia as a marker of outcome in patients with acute exacerbation of chronic obstructive pulmonary disease. Pneumonol Alergol Pol. 2015;83(5):348–351. doi:10.5603/PiAP.2015.0056